Drugmaker Raises U.S. Price of Muscular-Dystrophy Treatment

PTC Therapeutics Inc. this month increased the list price of its muscular-dystrophy treatment by about 9%, to more than $65,000 annually for a common dosage.

Popular Posts


EOF

(Visited 6 times, 1 visits today)

Vote on this story -->>>


this is a single

THE MIAMI METROPOLIS -your source for news, music, sports, movies, restaurants, reviews, weather, travel, arts, tech and events in Miami